-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NasdaqUSDISIN US83587F2020-
Sorrento Therapeutics IncBörse Börse FrankfurtEURSymbol 8STN
-
Sorrento Therapeutics IncBörse Börse BerlinEURSymbol 8STN
-
Sorrento Therapeutics IncBörse Börse MünchenEURSymbol 8STN
-
SORRENTO THERAPEUTICS INCBörse Börse DüsseldorfEURSymbol 8STN
-
SORRENTO THERAPEUTICS INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 8STN
-
SORRENTO THERAPEUTICS INCBörse Börse StuttgartEURSymbol 8STN
-
SORRENTO THERAPEUTICS INCBörse Gettex System der Börse MünchenEURSymbol 8STN
-
SORRENTO THERAPEUTICS INCBörse Quotrix System der Börse DüsseldorfEURSymbol 8STN
-
Sorrento Therapeutics IncBörse NasdaqISIN US83587F2020 WKN: A1W8DYUSDSymbol SRNE
-
ISIN US83587F2020 WKN: A1W8DYUSDSymbol SRNE
-
USD
-
ISIN US83587F2020
WKN A1W8DY
Symbol SRNE
Währung
USD
Börse
Nasdaq Zeitzone: Europe/Berlin
Firmenname
Sorrento Therapeutics, Inc
Marktkapitalisierung
2.808.609.792
Mitarbeiter
726 (+- 31%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
502 oder 949 Mitarbeiter
EBITDA -169.703.008
PEGRatio -0.07
Buchwert 0.617
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 8,04 EUR 0,00%
Entdecke die 6 ETFs in denen Sorrento Therapeutics, Inc am höchsten gewichtet ist Insgesamt in 7 ETFs enthalten
Dir gefallen die Informationen zu Sorrento Therapeutics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Sorrento Therapeutics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Sorrento Therapeutics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Sorrento Therapeutics Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
41 News & Informationen zur Sorrento Therapeutics Inc Aktie
Sorrento Therapeutics Announces Entry Into Option Agreement to Exclusively License MPRO Inhibitors Against SARS-CoV-2 and Variants of Concern, Including Delta, From Texas A&M University
MPro is a SARS-CoV-2 enzyme that catalyzes the formation of a number of essential proteins for the viral reproduction.MPro inhibitors block this catalytic process to potentially inhibit the… | August 24, 2021
Sorrento Publishes Positive Initial Results of SOFUSA® Lymphatic Drug Delivery System in a Phase 1b Rheumatoid Arthritis Study Using Enbrel
Rheumatoid Arthritis is one of many chronic autoimmune conditions affecting over 20 million people in the United States .Sofusa is a revolutionary technology which delivers biologic therapies… | August 23, 2021
Sorrento's vaccine shows promise against coronavirus, variants in animal studies
Sorrento Therapeutics Inc said on Thursday results https://www.biorxiv.org/content/10.1101/2021.08.17.456704v1.full.pdf from animal studies show its…
Sorrento Therapeutics : vaccine shows promise against coronavirus, variants in animal studies
Sorrento Therapeutics Inc said
on Thursday results https://www.biorxiv.org/content/10.1101/2021.08.17.456704v1.full.pdf
from animal studies show its experimental vaccine for COVID-19
has the potential… | August 19, 2021
Sabby Management, Llc Buys Cocrystal Pharma Inc, Enochian BioSciences Inc, Aterian Inc, Sells Second Sight Medical Products Inc, Asensus Surgical Inc, Penn National Gaming Inc
GuruFocus Article or News written by insider and the topic is about:
Dyadic International : AND SORRENTO ANNOUNCE BINDING TERM SHEET TO LICENSE 'S LEAD COVID-19 VACCINE CANDIDATE “DYAI-100” AND C1 TECHNOLOGY FOR PROTEIN-BASED CORONAVIRUS VACCINES AND THERAPEUTICS (Form
DYADIC AND SORRENTO ANNOUNCE BINDING TERM SHEET TO LICENSE DYADIC'S LEAD COVID-19 VACCINE CANDIDATE 'DYAI-100' AND C1 TECHNOLOGY FOR PROTEIN-BASED CORONAVIRUS VACCINES AND THERAPEUTICS
… | August 11, 2021
Sorrento Unveils Overview of Its MultiValent mRNA COVID-19 Vaccine Development Program
SAN DIEGO, Aug. 09, 2021 — Sorrento Therapeutics, Inc. , a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19, announced… | August 9, 2021
Sorrento Unveils Overview Of Its MultiValent MRNA COVID-19 Vaccine Development Program
SAN DIEGO, Aug. 09, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a clinical and commercial stage biopharmaceutical company
Increasing Adoption of Targeted Cancer Therapies to Propel Oncolytic Virus Immunotherapy Market, Says TMR
/PRNewswire/ — Oncolytic viruses are being increasingly used in cancer immunotherapy. A number of oncolytic viruses have been extensively studied in clinical…
Sorrento Therapeutics Proceeds with COVID-19 Drug Treatment Trial
Sorrento Therapeutics: Lots Of News Can Bring The Stock Up (NASDAQ:SRNE)
Sorrento Therapeutics is ready to market the COVI-STIX in Mexico with 25 million test units. The company is planning to file a BLA for the Infliximab biobetter in the US and the EU.
Delta Variant Infections of COVID Rising Quickly & Now Responsible for 83% of All U.S. Cases
/PRNewswire/ — According to WebMD, this week the nation's top health officials said Tuesday that the Delta variant of the coronavirus is racing through North…
Here is What Hedge Funds Think About Patria Investments Limited (PAX)
In this article we will check out the progression of hedge fund sentiment towards Patria Investments Limited (NASDAQ:PAX) and determine whether it is…
Sorrento Therapeutics Announces the Formation of Sorrento Therapeutics Mexico for Commercialization of COVI-STIX and Development of Sorrento's Portfolio of COVID-19 Products in Mexico and Parts of Lat
Sorrento Therapeutics has established a Subsidiary Company in Mexico – Sorrento Therapeutics Mexico.Sorrento’s Mexican importer of record has received an initial importation permit from… | July 20, 2021
Sorrento Therapeutics Stock: Sizing Up Again (NASDAQ:SRNE)
Sorrento Therapeutics is supported by bullish investors who see great potential from its substantial pipeline. See here for SRNE stock investment analysis.
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
Common stock of the merged company, Celularity, Inc., to commence trading on the Nasdaq Capital Market under the ticker symbol “CELU” on July 19, 2021 …
TL Private Wealth Buys Tilray Inc, Tilray Inc, Sells First Trust Dow Jones Internet Index Fund, Virgin Galactic Holdings Inc, Sorrento Therapeutics Inc
GuruFocus Article or News written by insider and the topic is about:
Why Sorrento Therapeutics Is Down 9% This Week
Investors apparently weren't impressed by good news about the company's promising RTX.
Why Sorrento Therapeutics Stock Gained 29% Last Month
The rally has more to do with the stock's pre-June circumstances than recent news.
FDA Clears Sorrento Phase 2 Trial Of Non-Opioid Product Candidate Resiniferatoxin (RTX) For Treatment of the Knee Pain in Osteoarthritis (OA) Patients
Phase 2 trial of RTX for OA pain to proceed following FDA clearance.Phase 1b data demonstrated RTX safety for a single intra-articular administration without dose limiting toxicity at any… | July 6, 2021
2 Biotech Stocks Wall Street Predicts Will Rally By More Than 150% By StockNews
2 Biotech Stocks Wall Street Predicts Will Rally By More Than 150%
Eyes Shift to the Healthcare Industry After the Pandemic Prompts a Reconsideration
NEW YORK, July 2, 2021 /PRNewswire/ — While the economy is slowly coming back to normal, concerns over the hyper-transmissible delta variant are rising. According to the CDC, the number of new…
Why Sorrento Therapeutics Is Climbing Today
Rising numbers of new COVID-19 cases might have investors anticipating strong demand for the company's 15-minute test.
Jim Cramer’s Top Picks to Close Out Q2 – 24
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
2 Meme Stocks to Avoid in the Healthcare Sector By StockNews
2 Meme Stocks to Avoid in the Healthcare Sector
Is A Fall In Sorrento Therapeutics Stock Imminent After A 28% Rise In A Month?
Earlier this month we discussed that the stock of Sorrento Therapeutics (NASDAQ: SRNE) is best avoided given the large rally it has seen in a short time period. While SRNE stock declined over 8% from levels of $9.46 on June 14 to $8.69 on June 21, it has since rallied 14% to $9.90 now…
Sorrento Therapeutics Forms Bullish Pattern, Options Traders Place Bets – Sorrento Therapeutics (SRNE)
Sorrento Therapeutics, Inc (NASDAQ:SRNE) shot up over 10% …
Why Sorrento Therapeutics Stock Jumped 10.6% Today
The company is setting up a subsidiary to launch its COVID-19 test in Mexico.
Sorrento Receives EUA Approval and Import License From Mexico Authority COFEPRIS For COVI-STIX™ (COVID-19 Virus Rapid Antigen Detection Test) and Plans Product Launch With Initial Shipments in July
Sorrento received official EUA registration and product import license: COFEPRIS EUA registration number “OFICIO: CAS/10720/2021”.Sorrento is establishing its “Sorrento Mexico… | June 24, 2021
Sorrento Therapeutics Stock: More Than Needle Replacement Therapy (NASDAQ:SRNE)
Sorrento Therapeutics has an antibody library and a diversified pipeline in life-threatening ailments. The variant-fighting capability of its COVID drug candidate should be in focus.
Sorrento Therapeutics to Acquire ACEA for $38M in Stock
These Nasdaq Biotech Stocks Doubled in 2020. Here's Why They're Soaring on Friday
Success tends to bring more success.
Sizing Up Sorrento Therapeutics, Again (NASDAQ:SRNE)
Dr. Henry Ji to Participate in the H.C. Wainwright Bioconnect 2021 Virtual Investor Conference
SAN DIEGO, Jan. 10, 2021 — Sorrento Therapeutics, Inc. , announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming conference: H.C. WAINWRIGHT… | January 10, 2021
Dr. Henry Ji To Participate In The H.C. Wainwright Bioconnect 2021 Virtual Investor Conference
SAN DIEGO, Jan. 10, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), announced today that Dr. Henry Ji, Chairman and CEO, will
Dr. Henry Ji to Participate in the H.C. Wainwright Bioconnect 2021 Virtual Investor Conference
SAN DIEGO, Jan. 10, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ:SRNE,
SPACs Attack Recap: SoFi, IPOE, GXGX, ACEV Deals Plus Rumors And Headlines For Week Ending January 8
The SPACs Attack show airs live on Benzinga YouTube Monday through Friday at 11 a.m. EST breaking down SPAC news and deals, and interviewing CEOs….
SPACs Attack Recap: SoFi, IPOE, GXGX, ACEV Deals Plus Rumors And Headlines For Week Ending January 8
The SPACs Attack show airs live on Benzinga YouTube Monday through Friday at 11 a.m. EST breaking down SPAC news and deals, and interviewing CEOs. Here is a …
California Biotech Advances Two COVID-19 Products
NexImmune Strengthens Scientific Leadership by Appointing Jerome Zeldis as EVP R&D and Jeffrey Weber as Chief Scientific Advisor
Zeldis formerly served as Celgene CMO and CEO of Celgene Global Health
Weber is a renowned melanoma specialist and leading immunotherapy translational and …